Article
Integrating plasma circulating protein-centered multi-omics to identify potential therapeutic targets for Parkinsonian cognitive disorders
12 May 2025
Abstract excerpt
BACKGROUND: Parkinson's disease (PD), the second most common neurodegenerative disease with notable clinical heterogeneity, has Parkinson disease dementia (PDD) that severely impacts patients' quality of life. As no effective treatment exists, this study aimed to find potential drug targets for PD cognitive disorders. METHODS: Two-sample Mendelian randomization (MR) and transcriptome analysis were used to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
